Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of DU-6859a in respiratory tract infection
jRCT2080220704Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sitafloxacin in Airways Infection and pneumonia, sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
sitafloxacin
03
Conditions
Airways Infectionpneumonia
Beyond the preview
Go deeper on jRCT2080220704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220704.